Clinical Trial Update: Studies of a Candidate Aminoquinoline Antimalarial (AQ-13) [Phase 2]

View source ↗

Summary

Phase 2 trials of AQ-13, a candidate aminoquinoline antimalarial, have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AQ-13

Snippet

Sponsor: Tulane University | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2024-07-11